RD. Map kinase phosphatase 5 protects against sepsis-induced acute lung injury.
lung inflammation; macrophages; cytokines ACUTE LUNG INJURY (ALI) is a major contributor to morbidity and mortality. In the United States alone, there are ϳ190,000 ALI cases, resulting in 74,500 deaths each year (32, 38, 43) . In several clinical conditions such as pneumonia, severe sepsis, pancreatitis and major trauma, ALI is partially caused by sustained and uncontrolled pulmonary inflammation characterized with rapid alveolar injury, cytokine production, and neutrophil infiltration. Hence innate immune system-mediated inflammation has been implicated in the process of ALI. Macrophages play a critical role in the pathogenesis of ALI, and depletion of alveolar macrophage in vivo dramatically ameliorates lung injury induced by mechanical ventilator or ischemiareperfusion (11, 25, 46) . After activation, macrophages generate several inflammatory mediators, such as proinflammatory cytokines, nitric oxide (NO) and reactive oxygen species (ROS), which in turn cause tissue injury. Proinflammatory cytokines such as TNF-␣ and IL-6 not only directly trigger lung injury but also lead to secondary inflammatory cascade including further activation of macrophages and upregulation of endothelial adhesion molecules that facilitate adhesion and migration of inflammatory cells (7, 15, 39) . In addition, active macrophages can also generate chemokines such as macrophage-inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine that facilitate the migration of neutrophils into the lung (2, 28) . NO and ROS produced by macrophages can cause tissue injury and decrease lung vascular integrity, resulting in elevated vascular permeability and sequential lung edema (4, 14, 27) .
As a major component of innate immunity, macrophages are activated by Toll-like receptors (TLRs) that recognize pathogen-associated molecular patterns (PAMP). Lipopolysaccharide (LPS) is an important PAMP, which is embedded in the outer membrane of Gram-negative bacteria and is associated with endotoxin-induced sepsis and ALI (36, 39) . LPS triggers macrophage activation through binding to TLR4, which forms an active complex with CD14 and MD2. Activation of TLR4 leads to the initiation of two main signal pathways, NF-B and MAPK, which induce the expression of proinflammatory mediators. The MAPK signal components, including p38 MAPK, JNK, and ERK, are involved in modulating the multiple functions of macrophages (1, 9, 30, 37) . Cytokine production is a critical inflammatory response for macrophage activation. p38 MAPK promotes transcription of TNF-␣ and IL-1␤ upon stimulation with LPS (24, 29) . JNK is involved in the regulation of many cytokine productions, such as TNF-␣, IL-6, and type I IFNs, in LPS-activated macrophages (8, 20, 42) . Although not affecting cytokine transcription, ERK modulates the stabilization of TNF-␣ mRNA in LPS-treated macrophages (10) . Productions of NO and ROS are also critical features that not only protect the host against bacterial and fungal infection but also induce tissue injury (4, 27) . p38 MAPK is involved in the modulation of NADPH oxidase activation, which in turn eliminates Escherichia coli (E. coli) infection in macrophages (23) . NO production in macrophages is mainly dependent on inducible NO synthase (iNOS) transcription, which can be induced by MAPK (19, 27) . Although these findings demonstrate that the MAPK signal pathways play a pivotal role in modulating macrophage functions, the negative regulatory mechanism for MAPK activation is still incompletely understood.
MAP kinase phosphatase 5 (MKP5, also called DUSP10) belongs to the family of cysteine-dependent dual-specificity phosphatases (DUSPs), which are important negative modulators through dephosphorylating the TXY motif of MAPKs (21, 26, 45) . MKP5 shows subcellular location in both cytoplasm and nucleus and is expressed ubiquitously in lung, liver, skeletal muscle, retina, spleen, and macrophages. Results from in vitro kinase assay show that MKP5 preferentially binds and inhibits the activation of p38 MAPK and JNK (34, 35) . However, endogenous MKP5 has different substrate preference in different cell types. MKP5-deficient T cells exhibit dramatically augmented JNK activity but no enhancement in p38 MAPK activity (44) . On the contrary, loss of MKP5 in neutrophils leads to markedly enhanced and prolonged p38 MAPK activity but no change in JNK activity (31) . Recent studies using MKP5-deficient mice have shown that MKP5 plays a pivotal role in immune system-related diseases. MKP5 is involved in experimental autoimmune encephalomyelitis and infection of lymphocytic choriomeningitis virus by regulating T cell functions (44) . Our previous study also shows that MKP5-deficient mice display a robust local Shwartzman reaction through modulation of neutrophil functions (31) . However, the contribution of MKP5 to lung inflammation has not been determined yet.
In this study, we report that MKP5 deficiency enhances p38 MAPK, JNK, and ERK phosphorylation in macrophages, leading to increased proinflammatory cytokine generation as well as enhanced NO and ROS production. In LPS-induced ALI model, we found that MKP5-deficient mice display more severe lung injury than wild-type (WT) controls. Mice that received MKP5-deficient macrophages are more prone to lung injury than those receiving WT macrophages, suggesting that MKP5-deficient macrophages directly contribute to lung inflammation. Collectively, these data indicate that MKP5 has a protective role against LPS-induced ALI.
MATERIALS AND METHODS
Animals. MKP5-deficient mice were generated and initially characterized as described previously (44) . WT littermates were used with the knockout mice in paired experiments. HLL mice expressing Photinus luciferase complementary DNA under a NF-B-dependent promoter (5= human immunodeficiency virus-1 long terminal repeat) were used as recipient mice in adoptive transfer experiments. Mice of 8 -12 wk of age were used in the study. All experiments involving mice were conducted with protocols approved by the Institutional Animal Care and Use Committee at the University of Illinois at Chicago.
Preparation of BMDMs. We used the method for bone marrow cell isolation as previously described (31) . Mouse bone marrow cells flushed from femurs and tibias were washed with Ca 2ϩ /Mg 2ϩ -free Hanks' balanced salt solution (HBSS). Contaminating erythrocytes were removed with the use of ACK buffer (150 mM NH 4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). After being washed, bone marrow cells were cultured in 10% FBS DMEM medium containing 15% L929 cell-conditioned medium. After 7 days, bone marrow-derived macrophages (BMDMs) (ϳ99% macrophages based on flow cytometry using anti-F4/80) were collected for experiments.
Measurement of cytokines and chemokines. In ex vivo cytokine detection, 2.5 ϫ 10 5 BMDMs in 200 l of 10% FCS or serum-free DMEM were placed in 48-well plates. Alternatively, 5 ϫ 10 4 alveolar macrophages were seeded into 96-well plates with a total volume of 100 l. After incubation overnight, cells were attached and stimulated with 100 ng/ml LPS (Sigma-Aldrich, St. Louis, MO), 100 ng/ml Pam3CSK4 (InvivoGen, San Diego, CA) or 5 g/ml lipoteichoic acid (LTA) (InvivoGen). The levels of IL-6, TNF-␣, and MIP-2 in cell culture medium were determined by ELISA assay (R&D Systems, Minneapolis, MN).
MAPK phosphorylation assay. Measurement of MAPK activation was performed as previously described (31) . BMDMs were plated in six-well plates at 2 ϫ 10 6 /well and starved in serum-free DMEM overnight. LPS was used to stimulate BMDMs for varying time intervals. Cells were then collected and lysed. The cell lysates were analyzed by Western blotting. Phosphorylation of MAPKs were detected by antibodies against p38 MAPK (Thr180/Tyr182), JNK (Thr183/Tyr185), ERK (Thr202/Tyr204), and total MAPKs (Cell Signaling Technology, Beverly, MA) and quantified by densitometry analysis using the ImageJ software (NIH, Bethesda, MD).
Measurement of NO production and iNOS expression. BMDMs in DMEM supplemented with 10% FCS were plated in six-well plates at 2 ϫ 10 6 /well overnight. BMDMs were then stimulated with 100 ng/ml LPS for 0, 6, 12, and 24 h. Culture medium was collected at different time points, and Griess reagent kit (Invitrogen, Carlsbad, CA) was used to detect NO in medium according to manufacturer's instruction. Meanwhile, the cell lysates were separated by SDS-PAGE, transferred to nitrocellulose membrane, and blotted with polyclonal anti-iNOS and anti-GAPDH antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).
Superoxide production assays. Superoxide production by BMDMs was determined in a luminol-enhanced chemiluminescence assay. BMDMs were seeded in 96-well white plate with reaction buffer containing 40 U of horseradish peroxidase (Invitrogen) and 100 M luminol (Sigma-Aldrich) in 1% BSA HBSS. After stimulation with Zymosan (Sigma-Aldrich), chemiluminescence was measured in a Wallac 1420 Multilabel Counter (Perkin Elmer Life Sciences, Norwalk, CT).
In vitro E. coli killing experiment. BMDMs were plated in 24-well plates at 5 ϫ 10 5 /well and incubated overnight at 37°C. BMDMs were then incubated with E. coli (25922, ATCC) at 1:10, 1:5, and 1:2.5 ratio of macrophages:E. coli for 1 h at 37°C. After 1 h, DMEM containing 200 g/ml of gentamycin (Cellgro, Herndon, VA) were replaced and incubated for 1 h to eliminate extracellular bacteria. Cells were then washed with HBSS twice and lysed with 0.5% Triton X-100 for 10 min on ice. Cell lysate was diluted and plated on soy-broth agar plates, and colonies were counted after incubation for overnight at 37°C.
Mouse model of LPS-induced ALI.
Mice were anesthetized by an intraperitoneal injection of 100 mg/kg ketamine and 5 mg/kg xylazine. After 10 min, the mice were suspended with their incisors to ϳ45°s upport by 3/0 suture. A cold-light source (Cambridge Instruments, Deerfield, IL) with two 25-inch flexible fiber-optic arms used to transilluminate the glottis. After mice were intratracheally instilled with 1 mg/kg LPS for 24 h, the lungs were excised and completely dried in an oven at 60°C for 3 days before calculation of lung wet-dry-ratio was made.
Histology. After mice were killed, the chest and abdomen were rapidly opened and the lung was instilled with 10% formalin through the trachea at a pressure of 20 -25 cm H2O. After 24-h fixation, lungs were embedded in paraffin and sections (5 m) were collected on microscope slides, deparaffinized, and stained with hematoxylin and eosin (Sigma-Aldrich).
Identification and detection of cytokines and inflammatory cells in BAL.
Mice were killed after CO 2 inhalation, and the lungs were lavaged with 1 ml Ca 2ϩ /Mg 2ϩ -free HBSS. After centrifugation at 3,000 rpm for 5 min, supernatant was collected, and proinflammatory cytokines were detected by ELISA. Total white blood cells in bronchoalveolar lavage (BAL) were counted. Cell smear was made using a cytospin (Thermo Electron, Cheshire, UK). The slides were stained using Hema-3 (Fisher Scientific, Kalamazoo, MI). Neutrophils and macrophages were identified and counted under microscopy with ϫ400 magnification.
Adoptive transfer of mouse macrophages to HLL mice and imaging. BMDMs (5 ϫ 10 6 /each mouse) in 30 l PBS were intratracheally injected into HLL mice. After overnight, the recipient HLL mice were intratracheally instilled with LPS (1 mg/kg). At 0 and 24 h, bioluminescent images were taken using an in vivo imaging system (IVIS, Xenogen IVIS-200; Caliper Life Sciences, Hopkinton, MA). For bioluminescence imaging, mice were anesthetized and shaved over the neck and chest. Luciferin (Caliper Life Sciences) was administered by intraperitoneal injection at 150 mg/kg in 150 l PBS 5-15 min before imaging, and mice were imaged to quantify in vivo luciferase activity by photon counting.
Statistical analysis. Data were expressed as means Ϯ SE. Differences between groups of mice were evaluated with Student's t-test. A P value Ͻ0.05 was considered statistically significant.
RESULTS

MKP5 deficiency facilitates proinflammatory cytokine production in LPS and Pam3CSK4-stimulated macrophages.
In innate immune response, MAPK signal pathways play a critical role in modulating cytokine production through TLRs (1, 3, 37) . Among these cytokines, IL-6 is a proinflammatory cytokine associated with inflammation, TNF-␣ is a proinflammatory cytokine that mediates tissue injury, and MIP-2 is a major chemokine for neutrophil recruitment. We measured cytokine production from WT and MKP5-deficient macrophages upon treatment with LPS (activating TLR4) and Pam3CSK4 (a TLR2 agonist). BMDMs from WT and MKP5-deficient mice were incubated with LPS or Pam3CSK4 for 0, 3 and 6 h. Culture media were then collected, and the level of selected cytokines was determined using ELISA. The production of IL-6, TNF-␣, and MIP-2 were markedly increased in WT and MKP5-deficient macrophages at 3 h and 6 h after LPS and Pam3CSK4 stimulation (Fig. 1, A-F) . Significantly more cytokines were produced in the absence of MKP5, suggesting that MKP5 negatively modulates the production of these proinflammatory cytokines in macrophages. To examine whether the regulation by MKP5 was limited to DMEM, we evaluated the cytokine production in MKP5-deficient alveolar macrophages. Upon stimulation for 16 h with LPS, Pam3CSK4, and LTA, which is another TLR2 agonist, MKP5 alveolar macrophages generated more IL-6, TNF-␣, and MIP-2 than WT macrophages (Fig. 1, G-I ). These data further confirm that MKP5 regulates proinflammatory cytokine production in lung alveolar macrophages. Fig. 1 . MAP kinase phosphatase 5 (MKP5) deficiency leads to increased IL-6, TNF-␣, and macrophage-inflammatory protein 2 (MIP-2) production. Wild-type (WT) and MKP5 knockout (KO) bone marrow-derived macrophages (BMDMs) (2.5 ϫ 10 5 ) were challenged with LPS (100 ng/ml) or Pam3CSK4 (100 ng/ml) for 0, 3, and 6 h (A-F). Alternatively, alveolar macrophages from WT and MKP5 KO mice were stimulated with LPS (100 ng/ml), Pam3CSK4 (100 ng/ml), and lipoteichoic acid (LTA) (5 g/ml) for 16 h (G-I). IL-6 (A, D, and G), TNF-␣ (B, E, and H), and MIP-2 (C, F, and I) in supernatants were detected by ELISA. *P Ͻ 0.05, **P Ͻ 0.01 compared with WT macrophages at same time points. Data shown are means Ϯ SE from 3 independent experiments.
MKP5 deficiency augments NO production in LPS-induced macrophages.
NO production is another characteristic of macrophage activation, which is associated with inflammation and regulated by the MAPK signal pathways (4, 27) . We examined whether MKP5 is involved in the regulation of NO production. WT and MKP5-deficient BMDMs were challenged with LPS, and the production of NO was measured using Griess reagent. After LPS stimulation, NO production in culture medium was increased in both WT and MKP5-deficient macrophages. However, MKP5-deficient macrophages produced two-and fourfold more NO than WT macrophages at 12 h and 24 h, respectively ( Fig. 2A) .
In macrophages, NO production is mainly dependent on iNOS expression. We therefore investigated whether MKP5 deficiency affected iNOS expression. In the absence of LPS challenge, no iNOS protein was detected in either WT or MKP5-deficient macrophages. In WT macrophages, LPS-induced expression of iNOS was detected within 6 h, continued to 12 h, and subsided after 24 h (Fig. 2B) . In comparison, iNOS expression was extended in MKP5-deficient macrophages. Densitometry analysis of the Western blots revealed that iNOS expression continued for 24 h after LPS stimulation (Fig. 2C) . These data indicate that, in WT macrophages, MKP5 suppresses NO production mainly through inhibition of iNOS expression.
MKP5 attenuates MAPK phosphorylation in LPS-treated macrophages. To investigate the physiological role of MKP5 in macrophages, we determined LPS-induced MAPK phosphorylation in the presence and absence of MKP5. In response to LPS stimulation, MKP5-deficient macrophages displayed enhanced phosphorylation of p38 MAPK, JNK, and ERK compared with WT macrophages (Fig. 3) . In the early phase after activation, MKP5-deficient macrophages showed significantly higher phosphorylation levels of p38 MAPK (30 min after activation) and JNK (60 min after activation) than WT macrophages. However, p38 MAPK and JNK were similarly phosphorylated in WT and MKP5-deficient macrophages 120 min after stimulation, indicating that the increased phosphorylation of these MAPKs was transient (Fig. 3, B and C) . In comparison, ERK phosphorylation in MKP5-deficient macrophages was sustained 120 min after LPS stimulation (Fig. 3D) . To determine whether enhanced MAPK phosphorylation is associated with inflammatory cytokine production, we detected the expression of IL-6, TNF-␣, and MIP-2 in the same serum-free condition in which WT and MKP5-deficient macrophages were starved overnight and challenged with LPS for 6 h. MKP5-deficient macrophages displayed enhanced ability for production of IL-6, TNF-␣, and MIP-2 (Fig. 3, E-G) . Collectively, although these data support that MKP5 negatively modulates p38 MAPK, JNK, and ERK in early phase, MKP5 deficiency preferentially alters ERK activation in late phase. Meanwhile, MKP5 deficiency leads to more inflammatory cytokine production in association with enhanced MAPK activity.
MKP5-deficient mice are more susceptible to LPS-induced ALI. Ex vivo experiments show that MKP5-deficient macrophages are more sensitive to LPS stimulation than the WT controls, leading to increased proinflammatory mediator production. To further investigate the role of MKP5 in vivo, we injected LPS intratracheally into WT and MKP5-deficient mice, which induces ALI. Lungs were excised 24 h after LPS administration for histological analysis. The lungs from MKP5-deficient mice displayed more tissue damage upon visual inspection (Fig. 4A ). The wet:dry ratio of the lung was determined as an index of pulmonary edema. The lungs of MKP5-deficient mice exhibited an increase in the wet:dry ratio compared with the WT controls (Fig. 4B) . Neutrophil infiltration is a marker for ALI. After intratracheal administration of LPS, BAL from WT and MKP5-deficient mice was obtained, and neutrophils and macrophages in the BAL were counted. More neutrophil accumulation was observed 4 h and 24 h after LPS injection (Fig. 4C) . However, the number of macrophages in BAL was similar between WT and MKP5-deficient mice. We also detect the levels of IL-6, TNF-␣, and MIP-2 in the BAL (Fig. 4D) . MKP5-deficient mice treated with LPS for 4 h generated more proinflammatory cytokines than WT mice (Fig.  4, E-G) . These data suggest that MKP5-deficient mice are highly susceptible to LPS-induced ALI.
MKP5-deficient macrophages directly contribute to LPSinduced lung injury.
Although macrophages play a pivotal role in inflammation, it is unclear whether MKP5-deficient macrophages are primarily responsible for the exacerbated lung injury, especially considering that MKP5 deficiency was sys- Fig. 2 . MKP5-deficient BMDMs generate more nitric oxide (NO) than WT BMDMs. MKP5 KO and WT BMDMs (2 ϫ 10 6 ) were stimulated with 100 ng/ml LPS for 0, 6, 12, and 24 h. A: NO produced in supernatant was detected using Griess reagent. B: expression of inducible NO synthase (iNOS) was detected by anti-iNOS antibody. C: expression level of iNOS was normalized against ␤-actin by using ImageJ software (NIH). *P Ͻ 0.05, **P Ͻ 0.01 compared with WT BMDMs at same time points. Data are means Ϯ SE from 3 independent experiments. temic due to the approach used for its gene deletion (44) . To evaluate an in vivo role for macrophages, we took advantage of the HLL transgenic mouse line (mice harboring an NF-Bdependent luciferase transgene) (33) . These mice (recipient) were given BMDMs from either WT or MKP5-deficient mice (the donor mice), and the ability of the adoptively transferred macrophages to mediate NF-B activation in vivo after LPS administration was measured based on whole-animal imaging. Approximately 5 ϫ 10 6 BMDMs were given intratracheally to each of the HLL mice. Sixteen hours later, LPS (1 mg/kg) was intratracheally administered. Bioluminescence images taken 24 h after LPS stimulation showed significantly more luciferase activity in the chest of HLL mice receiving MKP5-deficient BMDMs than in mice receiving WT BMDMs ( Fig. 5A; quantification in 5B). Because many inflammatory cytokines produced by macrophages stimulate NF-B activation, the result suggests that MKP5-deficient macrophages are more sensitive to LPS and contribute directly to the amplification of inflammatory signals. This finding is consistent with our ex vivo data showing that MKP5-deficient macrophages produce more IL-6 and TNF-␣ in response to LPS stimulation.
MKP5 deficiency leads to enhanced ROS production and E. coli clearance in macrophages. In response to zymosan, which led to phagocytosis, MKP5-deficient macrophages generated more superoxide than WT macrophages (Fig. 6A) . Quantification of cumulative superoxide production showed MKP5-deficient macrophages produced 53% more superoxide than WT macrophages when challenged with zymosan (Fig. 6B) . The result is consistent with our previous finding in neutrophils (31) and demonstrates that MKP5 also plays a role in regulating superoxide generation in macrophages. Because superoxide is critical to elimination of bacteria, we next determine whether loss of MKP5 might lead to more efficient bacterial clearance. Macrophages were incubated with E. coli at different cell-to-bacteria ratios (1:10, 1:5, and 1:2.5). We found MKP5-deficient macrophages were more capable of eliminating E. coli than WT macrophages at all three different ratios (Fig. 6C) . Meanwhile, MKP5-deficient macrophages displayed normal ability for E. coli phagocytosis (data not shown). Therefore, enhanced superoxide generation in MKP5-deficient macrophages may be translated to more efficient bacterial killing.
DISCUSSION
The present study demonstrates that mice lacking MKP5 display enhanced inflammatory response, shown as exacerbated lung injury when challenged with LPS. Adoptive transfer of MKP5-deficient macrophages to recipient HLL transgenetic mice led to a robust NF-B activation upon LPS stimulation, suggesting an active role for the macrophages in the observed lung injury. In ex vivo studies, MKP5 deficiency augmented production of proinflammatory factors including iNOS, chemokines, and proinflammatory cytokines. Along with these changes, there was an increase in LPS-induced phosphorylation of p38 MAPK, ERK, and JNK. Moreover, MKP5-deficient macrophages produced more superoxide than WT macrophages and were more effective in eliminating E. coli. Above all, these data suggest that MKP5 is an important signaling molecule that suppresses inflammatory tissue injury.
MAPKs, including p38 MAPK, JNK, and ERK, play fundamental roles in modulating immune cell functions. Although it is well established that MAPK activation requires a threetiered kinase cascade consisting of MAPKKK, MAPKK, and MAPK (5, 9), the negative regulatory mechanism for MAPK activation remains incompletely understood. Of the critical negative regulatory molecules, MKP5 (DUSP10), MKP1 (DUSP1), and phosphatase of activated cells (PAC-1) (DUSP2) are present in macrophages (17, 44, 47) . Previous gene-deletion studies have shown that MKP1 controls macrophage production of proinflammatory cytokines (6) and iNOS (41) . Mice lacking the MKP1 gene are more susceptible to septic Fig. 3 . MKP5-deficient BMDMs exhibit enhanced MAPK activation and inflammatory cytokine production. MKP5 KO and WT BMDMs (2 ϫ 10 6 ) were stimulated with 100 ng/ml LPS for 0, 15, 30, 60, 90, and 120 min. Cells were collected for immunoblotting. The phosphorylation of p38 MAPK, JNK, and ERK was detected using the respective anti-phospho-MAPK antibodies. The total p38 MAPK, JNK, and ERK were used as a loading control (A). Signal intensities of phosphorylated p38 MAPK (B), JNK (C), and ERK (D) were normalized against their respective loading control using ImageJ software (NIH). At the same serum-free culture condition, IL-6 (E), TNF-␣ (F), and MIP-2 (G) were detected 6 h after LPS stimulation at the concentration of 100 ng/ml. *P Ͻ 0.05, **P Ͻ 0.01 compared with WT macrophages at same time points. Data shown are means Ϯ SE from 3 independent experiments.
shock (47) , and these mice display enhanced host response to Gram-negative bacteria (40) . Our finding that MKP5 deficiency also impacts macrophage production of proinflammatory factors indicates that both of these phosphatases are involved in the negative regulation of macrophage response to LPS. Therefore, the two MKPs are not redundant and may work together to control inflammatory responses to bacterial products. It is notable that MKP1 deficiency increases bacterial burden (12), whereas our ex vivo results show that MKP5 deficiency enhances bacterial elimination. It is likely that MKP5 deficiency increases superoxide production, which is primarily responsible for elimination of engulfed bacteria. Unlike MKP1, which is a nuclear phosphatase, MKP5 is present in both the nucleus and the cytosol and can negatively regulate p38 MAPK activation in the cytosolic compartment. Therefore the localization of these MKPs may be important for their biological functions. For instance, MKP5 deficiency leads to increased NADPH oxidase activation and ROS production. In comparison, the nucleus-localized MKP1 primarily affects transcription but has little effect on the production of superoxide (31) .
After activation with LPS, deficiency of MKP5 led to enhanced phosphorylation of p38 MAPK, JNK, and ERK in macrophages. Our previous data show that, in neutrophils, MKP5 primarily regulates p38 MAPK but not JNK and ERK (31) . However, in lymphocytes, MKP5 regulates phosphoryla- Fig. 4 . MKP5 deficiency exacerbates lung injury. MKP5 KO and WT mice were intratracheally instilled with 1 mg/kg LPS. After 24 h, the mice were killed. The lungs were fixed with 10% formalin, and lung sections were stained with hematoxylin and eosin (A). The ratio of wet lung weight to dry lung weight was used as an index of pulmonary edema (B). After 0, 4, and 24 h, the lung was lavaged with 1 ml Hanks' balanced salt solution (Ca 2ϩ and Mg 2ϩ free). The neutrophils (C) and macrophages (D) in bronchoalveolar lavage (BAL) were counted. Meanwhile, IL-6 (E), TNF-␣ (F), and MIP-2 (G) in BAL at 0 and 4 h were detected by ELISA. *P Ͻ 0.05, **P Ͻ 0.01 compared with WT mice treated with LPS. Data are means Ϯ SE from 5 mice.
tion of JNK but not p38 MAPK and ERK (44) . These findings demonstrate that the substrate preference of MKP5 is cell dependent in immune cells (44) . This is different from in vitro studies, which shows a preference in the order of p38 MAPK Ն JNK ϾϾ ERK (34, 35) . Augmented ERK phosphorylation in MKP5-deficient macrophages may result from the lack of dephosphorylation of ERK by MKP5 or could be an indirect effect through a feedback signal pathway that remains to be investigated. Although both MKP5 and MKP1 dephosphorylate p38 MAPK and JNK, the phosphorylation pattern is different in macrophages lacking MKP1 or MKP5 when treated with LPS. In MKP5-deficient macrophages, LPS stimulation increases the phosphorylation of p38 MAPK and JNK in early phase (before 60 min). In contrast, in MKP1 deficient macrophages, a similar LPS stimulation enhances the phosphorylation of p38 MAPK and JNK in later phase (after 60 min) (47) . These results indicate that MKP5 and MKP1 cooperatively control the activation of MAP kinase cascades, in which MKP5 regulates the early phase of phosphorylation and MKP1 modulates the late phase of phosphorylation. The differences in regulating phosphorylation profiles may be caused by different subcellular localizations of MKP1 and MKP5, with MKP1 localizing to the nucleus and MKP5 localizing in both cytoplasm and nucleus (18, 21, 22) . Interestingly, PAC-1-deficient macrophages display increased JNK phosphorylation, decreased p38 MAPK phosphorylation, and no change in ERK phosphorylation after LPS stimulation (17) . These data indicate that the negative regulatory mechanism for MAP kinase cascades may be more complicated than previously thought, and different MAPK phosphatases may have distinct roles in regulating MAP kinase activation. Future research will need to focus on how these DUSPs cooperatively regulate MAPK signal pathways in macrophages.
Macrophages play key roles in innate immune responses including host defense and homeostasis of the immune system, in which MAPK signal pathways are required for modulating macrophage functions. It is previously reported that MAPK signal pathways are involved in the modulation of proinflammatory cytokine and NO production via activation of several essential transcriptional factors including activator protein-1, Elk-1, and cAMP response element-binding protein (9, 16) . Our study connects to these findings and shows that deficiency in MKP5 leads to enhanced MAP kinase activation, which in turn enhances the production of proinflammatory mediators including inflammatory cytokines, chemokines, NO, and ROS after macrophage activation through TLR4 or TLR2. In particular, the activated MKP5-deficient macrophages produced more TNF-␣, IL-6, and MIP-2 than WT controls (44) . In addition to proinflammatory cytokines, MKP5-deficient macrophages produced more NO as a result of increased iNOS expression. These data suggest that MKP5 modulates the expression of cytokines and iNOS through transcriptional regulation. During our investigation of the MKP5-deficient macrophages, we found that superoxide generation was also enhanced in MKP5-deficient macrophage after activation with zymosan, which is an agonist for TLR2 and Dectin-1 (13) . The enhanced superoxide production may contribute to the increased ability of MKP5-deficient macrophages to clear E. coli, especially considering that phagocytosis by the MKP5-deficient macrophages was unaltered. To date, only MKP5 has been found to regulate NADPH activation, suggesting that this DUSP differs from MKP1 and PAC-1. These latter phosphatases may not be involved in regulating NADPH activation because of their localization in the nucleus. In contrast, MKP5 is found both in the nucleus and in cytoplasm (34, 35) . Therefore, it is expected that MKP5 is involved in transcriptional regulation in the nucleus as well as in TLR-mediated macrophage kinase activation in the cytoplasm.
Given that MKP5 plays a protective role in regulating macrophage functions, we predicted that the MKP5-deficient mice might have a stronger innate immune response. By using a mouse model of LPS-induced ALI, we found that deficiency in MKP5 triggered severe lung injury, including enhanced lung edema and increased neutrophil infiltration. Similar results were also obtained from MKP1-deficient mice, which displayed enhanced pathological response to LPS and bacterial infection, thus aggravating lung injury (12, 40, 47) . These data further confirm that MKP5 and MKP1 complement each other in controlling excessive inflammatory responses, and the loss of either gene may lead to severe consequences. Adoptive transfer of MKP5-deficient macrophages to HLL mice renders these mice highly responsive to LPS, suggesting that MKP5-deficient macrophages are major contributors to LPS-induced lung injury in the model system. Many of the proinflammatory mediators produced by macrophages have been linked to the pathogenesis of ALI, including production of various proinflammatory cytokines and chemokines (TNF-␣, IL-6, and MIP-2), among which TNF-␣ and IL-6 directly induce tissue damage, whereas MIP-2 contributes to neutrophil accumulation. In addition, NO enhances vascular permeability, whereas ROS contributes to tissue injury. Although it has not been defined which mediator plays a more important role in LPS-induced lung injury, it is likely that these proinflammatory mediators have a synergistic effect on LPS-induced ALI.
Antimicrobial infection is another important function of macrophages. In vitro bacterial clearance studies showed that MKP5 is involved in homeostatic regulation of bacterial killing in macrophages. This is accomplished in part by increasing the production of superoxide in MKP5-deficient macrophages, whereas phagocytosis is unaffected by MKP5 deficiency. We previously report that MKP5-deficient neutrophils generate more superoxide upon formyl-Met-Leu-Phe stimulation, and neutrophil-derived ROS also contributes to tissue damage (31) . Meanwhile, loss of MKP5 in macrophages leads to an increase in NO production, which is a potent antibacterial molecule (27) . These results indicate that MKP5 limits bactericidal activity through controlling ROS and NO generation.
In summary, our results demonstrate a homeostatic function of MKP5 that is critical to the maintenance of host defense while limiting overproduction of inflammatory cytokines and tissue-damaging oxygen radicals. A part of these functions takes place in macrophages, which contributes significantly to ALI through proinflammatory cytokine production, NO generation, and NADPH activation. In vivo studies show that MKP5 is a negative regulatory molecule in LPS-induced ALI. Effective anti-inflammatory therapies might be developed based on the mechanisms of this homeostatic regulation.
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